Alvotech (ALVO) stock is in focus as the company partners with Advanz Pharma to market three additional biosimilars across ...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to ...

Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic ...

Alvo Minerals Limited has announced an update to a previous announcement regarding a proposed issue of securities. The company will remain in voluntary suspension until the comple ...